Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physical exercise, sport, psychiatry, and mental health.

PCN reports : psychiatry and clinical neurosciences·2026
Same author

Current Clinical Psychopharmacology Integrated Practice: The Crisis in Teaching and Its Effects on Quality of Care.

Journal of clinical psychopharmacology·2026
Same author

Brain Injuries, Illness, and Treatment in Sports: It's Not All in the Mind.

The primary care companion for CNS disorders·2025
Same author

The evolution of sports psychiatry: a clinical intersection of mental health and physical activity.

British journal of sports medicine·2025
Same author

Envisioning an improved research strategy for detecting moderators/mediators in intervention studies: A commentary on McClure et al.

The International journal of eating disorders·2024
Same author

The Role of Families in Psychiatric and Medical Care.

The Journal of nervous and mental disease·2022

Related Experiment Video

Updated: Jun 19, 2026

Reversible Cooling-induced Deactivations to Study Cortical Contributions to Obstacle Memory in the Walking Cat
09:43

Reversible Cooling-induced Deactivations to Study Cortical Contributions to Obstacle Memory in the Walking Cat

Published on: December 11, 2017

Clinical trials design lessons from the CATIE study.

Helena Chmura Kraemer1, Ira D Glick, Donald F Klein

  • 1Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA 94301, USA. hckhome@pacbell.net

The American Journal of Psychiatry
|October 3, 2009
PubMed
Summary
This summary is machine-generated.

The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study highlighted design challenges in schizophrenia drug trials. Future research should refine methods for clearer results on antipsychotic effectiveness.

More Related Videos

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Reversible Cooling-induced Deactivations to Study Cortical Contributions to Obstacle Memory in the Walking Cat
09:43

Reversible Cooling-induced Deactivations to Study Cortical Contributions to Obstacle Memory in the Walking Cat

Published on: December 11, 2017

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

  • Psychiatry
  • Clinical Trials Methodology
  • Pharmacological Research

Background:

  • The National Institute of Mental Health funded the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study to assess schizophrenia drug efficacy.
  • This analysis focuses on the methodological and design aspects of the CATIE study, rather than its direct conclusions.
  • The goal is to inform appropriate clinical interpretation and improve future large-scale clinical trials.

Purpose of the Study:

  • To critically evaluate the design and methods employed in the CATIE study.
  • To identify strengths and weaknesses in the CATIE study's approach to comparing antipsychotic medications.
  • To provide recommendations for enhancing the design and execution of future clinical trials in schizophrenia research.

Main Methods:

  • Analysis of design decisions within the CATIE study, including randomization, number of interventions, and outcome measures.
  • Examination of statistical power considerations in relation to study size and design complexity.
  • Review of the implications of study design choices for interpreting treatment effectiveness and equivalence.

Main Results:

  • The CATIE study, despite its large participant group, faced challenges with statistical power due to design elements.
  • Issues identified include multiple treatment interventions, unbalanced randomization, and numerous secondary outcomes.
  • The study's design decisions necessitate careful interpretation, particularly regarding statistically nonsignificant findings.

Conclusions:

  • While CATIE offered valuable insights, its design elements like multiple interventions and unbalanced randomization impacted its power.
  • Clarifying study intent—superiority versus equivalence—is crucial for appropriate design and analysis.
  • Future trials could benefit from fewer sites, more subjects per site, fewer treatments, and fewer outcomes to achieve definitive results more cost-effectively.